PREVAIL_1A: PREVAIL, figure 1A

PREVAIL_1AR Documentation

PREVAIL, figure 1A

Description

Kaplan-Meier digitized data from PREVAIL, figure 1A (PMID 24881730). A reported sample size of 1,717 for a primary endpoint of PFS/OS in prostate cancer.

Usage

PREVAIL_1A

Format

A data frame of 1,633 observations and 3 variables:

time event time (in months)
event RPFS event indicator (0: no event, 1: event)
arm treatment arms (enzalutamide, placebo)

Source

Beer TM, Armstrong AJ, Rathkopf DE, et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med 2014; 371: 424–33.

Examples

summary(PREVAIL_1A)

kmplot(PREVAIL_1A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.